DPP-IV inhibitors for treatment of diabetes in paediatric patients

Details for Australian Patent Application No. 2010209705 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Graefe-Mody, Eva Ulrike; Neubacher, Dietmar; Rauch, Thomas; Woerle, Hans-Juergen

Agent Spruson & Ferguson

Pub. Number AU-A-2010209705

PCT Pub. Number WO2010/086411

Priority 09151662.5 29.01.09 EP

Filing date 29 January 2010

Wipo publication date 5 August 2010

International Classifications

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/522 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

7 July 2011 PCT application entered the National Phase

  PCT publication WO2010/086411 Priority application(s): WO2010/086411

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010209709-Method for setting an output voltage level of a wind power plant

2010209695-Antibiotic peptides